Examkin

Question

Difficulty: MediumStudy Design

A group of neurologists at a large regional healthcare network is investigating the association between long-term use of a specific calcitonin gene-related peptide (CGRP) antagonist and the incidence of new-onset hypertension. They query the network's electronic health record (EHR) database to identify all adult patients diagnosed with chronic migraine between 2018 and 2021. Patients are stratified into two groups: those who were prescribed the CGRP antagonist for at least 12 months, and those who were treated solely with other prophylactic medications. The researchers then analyze the EHR data longitudinally through 2025 to determine the proportion of patients in each group who subsequently received a new diagnosis of hypertension. Which of the following statements accurately describe the methodological characteristics of this study design? (Select all that apply)

  1. It allows for the direct calculation of incidence rates and relative risk.Answer
  2. The use of pre-existing medical records minimizes the risk of recall bias regarding medication exposure.Answer
  3. C
    It provides better protection against confounding by indication compared to a randomized controlled trial.
  4. D
    The primary measure of association for this design must be the odds ratio because absolute incidence cannot be determined.
  5. E
    The participant selection process initially groups individuals based on the presence or absence of the primary outcome.

Answer

The correct statements are that the study allows for the direct calculation of incidence rates and relative risk, and that using pre-existing medical records minimizes recall bias.
The clinical scenario describes a retrospective cohort study. The researchers identified a cohort of patients based on their past exposure to a specific medication (the CGRP antagonist) and tracked their electronic health records forward in time to measure the development of a new outcome (hypertension). Because cohort studies track initially disease-free individuals over a defined risk period, they allow for the direct measurement of incidence and the calculation of relative risk (risk ratios). Furthermore, by utilizing objective, pre-existing electronic health records to determine exposure status, this design fundamentally avoids the recall bias that frequently limits studies relying on patient interviews or questionnaires.

Step-by-Step Solution

1
Identify the study design described in the vignette.
The design is a retrospective cohort study.
Participants are identified based on past exposure status (CGRP antagonist vs. other medications) and followed forward in historical time to assess for the development of a subsequent outcome (hypertension).
2
Evaluate the statistical measures applicable to a retrospective cohort design.
Incidence rates and relative risk can be directly calculated.
Cohort studies track initially disease-free populations over time, allowing for the observation of new cases (incidence) and the direct comparison of risk between exposed and unexposed groups.
3
Evaluate the specific biases associated with the described data collection method.
Recall bias is minimized.
Exposure status is determined via objective, pre-existing electronic health records rather than relying on patient memory, thereby eliminating differential recall between the groups.

Key Concept

Retrospective Cohort Study Methodology and Bias Recognition
Rate this question

Topics

Study Design

More questions from this topic